Applying control theory to medicine: measure, decide, correct. Today that means Rokan Health.
Founder, Rokan Health Control theory at ETH Zurich, Politecnico di Milano and KAUST Forbes Italia 30 Under 30
ContactStudied and worked at
About
Guido Putignano is an engineer and the founder of Rokan Health.
He has worked on control theory at ETH Zurich, Politecnico di Milano and KAUST, and applied it to cell and gene therapies in oncology and to lab automation at Harvard, the MIT Media Lab and ETH Zurich.
His path also runs through the Amgen Scholars programme in Cambridge (UK) and Basel and the Foresight Institute in San Francisco. He is a licensed engineer in Italy.
The idea
Control theory is the mathematics of systems that steer themselves: measure, decide, correct, and repeat.
Measure
Read the state of the system as it is: a cell culture, a lab process, a patient.
Decide
Compare it with the goal and use a model to choose the next action.
Correct
Act, then measure again. The same loop runs through all of the work: cell therapies, lab automation, and now how patients are treated.
Path
Labs and institutions across Europe, the United States and Saudi Arabia.
-
2026
Thuwal KAUST
Visiting student researcher (VSRP)
-
2026
Riyadh bioERGOtech
Making biology work like technology
-
2025
Rome bioERGOtech
Built a foundation that helps people develop digital scientists
-
2024
Boston MIT Media Lab
SUD Venture Program
-
2023–2025
Zurich ETH Zurich
Control theory; master’s degree
-
2023
Boston Harvard
Internship
-
2023
San Francisco Foresight Institute
Longevity Fellowship
-
2023
Cambridge, UK Amgen Scholars
Amgen Scholar
-
2023
Basel Amgen Scholars
Amgen Scholar
-
2020–2023
Milan Politecnico di Milano
Control theory
Rokan Health
Abundance, made clear.
Medicine now lives in an era of abundance: data, information, drugs. The hard part is managing it. Rokan Health works on clearing the decision layer of how patients are treated.
rokanhealth.comSelected work
Research and writing on biology, AI and medicine.
-
Review · Co-author
2025
Modelling sex differences of neurological disorders in vitro
How models of brain disorders, from cell lines to organoids and organ-on-a-chip systems, can account for differences between male and female brains.
-
Review · Co-author
2023
Towards AI-driven longevity research: an overview
How AI methods are used to analyse proteomic, genomic and phenomic data in longevity research and drug discovery.
-
Article · Contributor
2022
AI ethics for children: digital natives on how to protect future generations
On protecting children as AI becomes part of their toys, classrooms and homes.
Recognition
Fellowships, awards and programmes.
-

Forbes Italia 30 Under 30
Science
-

Emergent Ventures
Grantee, Mercatus Center
-

Clinton Foundation
Fellowship
-

Foresight Institute
Longevity Fellowship
-

Aspen Institute Italia
Member
-

Premio Italia Giovane
Award
-
Amgen Scholars
Cambridge (UK) and Basel
Contact
For clinicians, hospitals, investors, researchers, press and event organisers.
guido.putignano@rokanhealth.com
